Impact of Type II LRRK2 inhibitors on signaling and mitophagy. (2021)

First Author: Tasegian A
Attributed to:  Understanding Signalling Pathways Mutated in Inherited Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1042/bcj20210375

PubMed Identifier: 34515301

Publication URI: http://europepmc.org/abstract/MED/34515301

Type: Journal Article/Review

Volume: 478

Parent Publication: The Biochemical journal

Issue: 19

ISSN: 0264-6021